# TG Therapeutics, Inc.: Form 8-K, filed Mar 20, 2026

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: 8-K
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 16:33 ET
- Period: 2026-03-18
- Accession: 0001437749-26-009253
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000143774926009253/tgtx20260319_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000143774926009253/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000143774926009253/tgtx20260319_8k.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-009253. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.